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June 4, 2013:2310–7However, the annual event rate rose after the first 3 years,
indicating that in patients with persistent or recurrent stable chest
pain syndrome and initially negative stress testing, repeated
DCMR diagnostic procedures might be warranted.
Furthermore, early revascularization either by PCI or CABG
both improved clinical outcome only in patients with inducible
WMA by DCMR, whereas patients who underwent revascular-
ization in the absence of inducible ischemia showed no significant
benefit from invasive treatment. This is in agreement with recent
randomized multicenter trials, where only patients with ischemia
benefited from invasive procedures (11,12).
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Letters to the Editor
Long-Term Survival of Young
Patients With Coronary Artery
Disease Is Best Realized Through
Surgical Revascularization
With Mammary Arteries
In a recent issue of the Journal, Flather et al. (1) reported a
subgroup analysis of individual patient data from 10 randomized
trials comparing percutaneous coronary intervention (PCI) and
coronary artery bypass grafting (CABG) for multivessel coronary
disease. Their analysis showed that there was a significant treat-
ment by age interaction for 10-year mortality (p  0.001).
Strikingly enough, in the youngest group of patients (56.2 years
of age), there was no difference in mortality (hazard ratio [HR] for
PCI: 1.23; 95% CI: 0.95 to 1.59), whereas the HR shifted toward
a significant benefit of CABG over PCI in older patients (65.2
years of age) (HR: 0.79; 95% CI: 0.67 to 0.94).
Although the data from these trials are compelling, the trials
were not performed according to the “all-comers” design, and it is
therefore likely that there was a severe selection bias in the
inclusion of patients. Young patients were probably those with low
lesion complexity, and it is known that CABG does not offer a
survival benefit in these patients (2). In contrast, even though the
RR
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elderly patients, this is counterintuitive and these results may not
be generalizable to the majority of patients requiring coronary
revascularization. Those patients with a higher risk profile were
likely to be excluded from randomization because of procedural
risks associated with CABG (3). The advantage of PCI in the
elderly patients could therefore not be identified in this pooled
analysis.
Furthermore, long-term survival of young patients with more
complex coronary artery disease is best realized through surgical
revascularization with a left internal mammary artery (IMA) to
the left anterior descending artery and additional arterial grafts
(preferably the right IMA) to other major coronaries. This will
optimize long-term survival due to excellent graft patency (4),
which is critical, especially in young patients with a relatively
long life expectancy (5). Young patients who undergo PCI will
have a high risk of multiple repeat revascularizations and are
susceptible to the associated procedural risks.
The ancillary benefit of PCI over CABG is its lesser invasive-
ness and shorter initial hospitalization (6). However, in younger,
fitter patients, CABG is appealing because of low complication
rates, short lengths of stay, and little time needed to resume normal
activities of daily living. The benefit of PCI over CABG in
younger patients may therefore be small, whereas long-term
efficacy is clearly superior in the majority of young patients; the
treatment of choice should therefore be CABG.
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2012;33:1318–24.Prognostic Value of
Multidetector Coronary Computed
Tomography Angiography
Cho et al. (1) should be commended for their recent attempt to
answer an important question in an ongoing debate on the
prognostic value of coronary computed tomography angiography
(CCTA). In their retrospective cohort study from a single center,
they concluded that CCTA provided improved discrimination for
future major adverse cardiovascular events over the exercise stress
test (1). However, it should be noted that:
1. Results of the current study were predominantly based on a
clinician-driven outcome—revascularization, which is more
amenable to change and should be interpreted with great
caution. The difference in prognostic value of the exercise stress
test and CCTA (for both negative and positive tests) failed to
achieve statistical significance for more relevant clinical out-
comes—cardiac death and nonfatal myocardial infarction.
Thus, the CCTA-based approach led to a higher rate of
revascularization, but it remains unclear whether the CCTA-
guided therapeutic decision-making process led to improve-
ment in outcomes in terms of hard clinical endpoints.
2. The researchers censored the outcomes by excluding revascu-
larizations that occurred 90 days after the index test to avoid
a confounding effect of CCTA driving the study endpoint.
However, such selective removal of patients creates treatment
selection bias and results in greater observed risk reduction
among patients with obstructions as compared with those
without obstructions.
Despite the high radiation exposure, higher cost, unproven
clinical benefits, and inability to provide useful clinical information
in the settings of high heart rate, coronary calcification, and
obesity—which are rampant among patients with coronary artery
disease (2)—should we really advocate CCTA as a first-line test
for more than 5 million Americans who present to the emergency
department every year with chest pain (3)?
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